302 related articles for article (PubMed ID: 15205180)
1. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
Keane MP; Belperio JA; Arenberg DA; Burdick MD; Xu ZJ; Xue YY; Strieter RM
J Immunol; 1999 Nov; 163(10):5686-92. PubMed ID: 10553099
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
[TBL] [Abstract][Full Text] [Related]
4. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.
Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S
Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251
[TBL] [Abstract][Full Text] [Related]
5. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
6. Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
Jiang D; Liang J; Hodge J; Lu B; Zhu Z; Yu S; Fan J; Gao Y; Yin Z; Homer R; Gerard C; Noble PW
J Clin Invest; 2004 Jul; 114(2):291-9. PubMed ID: 15254596
[TBL] [Abstract][Full Text] [Related]
7. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
Burdick MD; Murray LA; Keane MP; Xue YY; Zisman DA; Belperio JA; Strieter RM
Am J Respir Crit Care Med; 2005 Feb; 171(3):261-8. PubMed ID: 15502109
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis.
Kimura T; Ishii Y; Yoh K; Morishima Y; Iizuka T; Kiwamoto T; Matsuno Y; Homma S; Nomura A; Sakamoto T; Takahashi S; Sekizawa K
Am J Pathol; 2006 Jul; 169(1):96-104. PubMed ID: 16816364
[TBL] [Abstract][Full Text] [Related]
9. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Sakamoto H; Zhao LH; Jain F; Kradin R
Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
[TBL] [Abstract][Full Text] [Related]
10. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
11. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
Keane MP; Arenberg DA; Lynch JP; Whyte RI; Iannettoni MD; Burdick MD; Wilke CA; Morris SB; Glass MC; DiGiovine B; Kunkel SL; Strieter RM
J Immunol; 1997 Aug; 159(3):1437-43. PubMed ID: 9233641
[TBL] [Abstract][Full Text] [Related]
12. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
Izumo T; Kondo M; Nagai A
Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin-induced lung inflammation and fibrosis.
How CK; Chien Y; Yang KY; Shih HC; Juan CC; Yang YP; Chiou GY; Huang PI; Chang YL; Chen LK; Wang CY; Hsu HS; Chiou SH; Lee CH
Shock; 2013 Mar; 39(3):261-70. PubMed ID: 23364435
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
Cabrera S; Gaxiola M; Arreola JL; Ramírez R; Jara P; D'Armiento J; Richards T; Selman M; Pardo A
Int J Biochem Cell Biol; 2007; 39(12):2324-38. PubMed ID: 17702637
[TBL] [Abstract][Full Text] [Related]
15. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
16. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
[TBL] [Abstract][Full Text] [Related]
18. Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I.
Kikuchi N; Ishii Y; Morishima Y; Yageta Y; Haraguchi N; Yamadori T; Masuko H; Sakamoto T; Yanagawa T; Warabi E; Ishii T; Hizawa N
Am J Respir Cell Mol Biol; 2011 Sep; 45(3):600-9. PubMed ID: 21239607
[TBL] [Abstract][Full Text] [Related]
19. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
